Proscillaridin
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | C01AB01 (WHO) |
Identifiers | |
| |
Synonyms | 3β-Rhamnosido-14β-hydroxybufa-4,20,22-trienolide |
CAS Number | 466-06-8 |
PubChem (CID) | 5284613 |
ChemSpider | 4447658 |
UNII | KC6BL281EN |
ChEMBL | CHEMBL600325 |
ECHA InfoCard | 100.006.702 |
Chemical and physical data | |
Formula | C30H42O8 |
Molar mass | 530.650 |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Proscillaridin is a cardiac glycoside, a kind of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). It is of the bufanolide type and can be obtained from plants of the genus Scilla and in Drimia maritima (Scilla maritima).[1]
The aglycone of proscillaridin is scillarenin.
References
This article is issued from Wikipedia - version of the 11/24/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.